BACKGROUND: This single-center study sought to examine the clinical outcomes of kidney transplant recipients from donors displaying acute kidney injury (AKI). METHODS: We analyzed retrospectively the medical records of the donors and recipients of 54 deceased-donor kidney transplantations performed in our center between March 2009 and March 2012. RESULTS: Among the 54 deceased donors, 36 (66.7%) experienced AKI as determined by the final mean serum creatinine levels measured before graft harvest of 2.66 ± 1.62 mg/dL versus 0.82 ± 0.28 mg/dL among non-AKI donors. The risks of delayed graft function and slow graft function were increased among the AKI versus non-AKI groups in the early post-transplantation period. However, the renal function status of recipients at 3, 6, and 12 months after transplantation was not significantly different between the two groups. Moreover, rejection-free survival rates during the study period were similar. Multivariate analysis revealed an acute rejection episodes (P = .047) and a lower body mass index in the donor relative to the recipient (P = .011) to be independent risk factors predicting poor graft function defined as a 1-year estimated glomerular filtration rate less than 50 mL/min/l.73 m(2). Donor AKI with either a high level (>4.0 mg/dL), an increasing trend of creatinine, or greater severity by the Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) classification was not a significant risk factor. CONCLUSION: Transplantation of kidneys from the AKI donors, namely, patients with severely decreased renal function, displayed excellent short-term outcomes. Accordingly, kidney transplantations from deceased donors with AKI should be considered more actively to expand the donor pool in Korea.
BACKGROUND: This single-center study sought to examine the clinical outcomes of kidney transplant recipients from donors displaying acute kidney injury (AKI). METHODS: We analyzed retrospectively the medical records of the donors and recipients of 54 deceased-donor kidney transplantations performed in our center between March 2009 and March 2012. RESULTS: Among the 54 deceased donors, 36 (66.7%) experienced AKI as determined by the final mean serum creatinine levels measured before graft harvest of 2.66 ± 1.62 mg/dL versus 0.82 ± 0.28 mg/dL among non-AKI donors. The risks of delayed graft function and slow graft function were increased among the AKI versus non-AKI groups in the early post-transplantation period. However, the renal function status of recipients at 3, 6, and 12 months after transplantation was not significantly different between the two groups. Moreover, rejection-free survival rates during the study period were similar. Multivariate analysis revealed an acute rejection episodes (P = .047) and a lower body mass index in the donor relative to the recipient (P = .011) to be independent risk factors predicting poor graft function defined as a 1-year estimated glomerular filtration rate less than 50 mL/min/l.73 m(2). Donor AKI with either a high level (>4.0 mg/dL), an increasing trend of creatinine, or greater severity by the Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) classification was not a significant risk factor. CONCLUSION: Transplantation of kidneys from the AKI donors, namely, patients with severely decreased renal function, displayed excellent short-term outcomes. Accordingly, kidney transplantations from deceased donors with AKI should be considered more actively to expand the donor pool in Korea.
Authors: Isaac E Hall; Enver Akalin; Jonathan S Bromberg; Mona D Doshi; Tom Greene; Meera N Harhay; Yaqi Jia; Sherry G Mansour; Sumit Mohan; Thangamani Muthukumar; Peter P Reese; Bernd Schröppel; Pooja Singh; Heather R Thiessen-Philbrook; Francis L Weng; Chirag R Parikh Journal: Kidney Int Date: 2018-11-20 Impact factor: 10.612
Authors: I E Hall; B Schröppel; M D Doshi; J Ficek; F L Weng; R D Hasz; H Thiessen-Philbrook; P P Reese; C R Parikh Journal: Am J Transplant Date: 2015-03-11 Impact factor: 8.086
Authors: Jeong Ho Kim; Young Soo Kim; Min Seok Choi; Young Ok Kim; Sun Ae Yoon; Ji-Il Kim; In Sung Moon; Bum Soon Choi; Cheol Whee Park; Chul Woo Yang; Yong-Soo Kim; Byung Ha Chung Journal: BMC Nephrol Date: 2017-01-27 Impact factor: 2.388
Authors: Jana Bauer; Sascha Grzella; Malwina Bialobrzecka; Lea Berger; Timm H Westhoff; Richard Viebahn; Peter Schenker Journal: Ann Transplant Date: 2018-12-07 Impact factor: 1.530
Authors: Kyung Jai Ko; Young Hwa Kim; Mi Hyeong Kim; Kang Woong Jun; Kyung Hye Kwon; Hyung Sook Kim; Sang Dong Kim; Sun Cheol Park; Ji Il Kim; Sang Seob Yun; In Sung Moon; Jeong Kye Hwang Journal: Ann Surg Treat Res Date: 2018-10-25 Impact factor: 1.859
Authors: Juan Pei; Yeoungjee Cho; Yong Pey See; Elaine M Pascoe; Andrea K Viecelli; Ross S Francis; Carolyn van Eps; Nicole M Isbel; Scott B Campbell; Philip A Clayton; Jeremy Chapman; Michael Collins; Wai Lim; Wen Tang; Germaine Wong; Carmel M Hawley; David W Johnson Journal: PLoS One Date: 2021-03-25 Impact factor: 3.240
Authors: Neel Koyawala; Peter P Reese; Isaac E Hall; Yaqi Jia; Heather R Thiessen-Philbrook; Sherry G Mansour; Mona D Doshi; Enver Akalin; Jonathan S Bromberg; Meera N Harhay; Sumit Mohan; Thangamani Muthukumar; Bernd Schröppel; Pooja Singh; Francis L Weng; Chirag R Parikh Journal: Transplantation Date: 2020-06 Impact factor: 5.385